Pilot Study of Viral Load and Transcription in Kaposi's Sarcoma Patients Treated With Liposomal Anthracyclines.

Trial Profile

Pilot Study of Viral Load and Transcription in Kaposi's Sarcoma Patients Treated With Liposomal Anthracyclines.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 05 Aug 2015

At a glance

  • Drugs Daunorubicin liposomal (Primary)
  • Indications Kaposi's sarcoma
  • Focus Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 01 Dec 2011 Actual patient number is 14 according to ClinicalTrials.gov.
    • 01 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
    • 01 Dec 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top